Wednesday, 26 August 2026European Markets

FINATIS Stock Bearish Momentum With A 24% Slide In The Last 10 Sessions

Loading stream...

(vianews) - shares of finatis (cac 40: fnts.pa) slid by a staggering 24.37% in 10 sessions from €5.95 to €4.50 at 01:57 est on monday, after four successive sessions in a row of losses. cac 40 is rising 0.88% to €7,348.12, after two successive sessions in a row of gains.

about finatis

finatis société anonyme engages in food distribution activities in france and latin america. it operates monoprix, franprix, casino supermarkets, petit casinos, casino shops, spars, vivals, géant hypermarkets, etc. the company also distributes sports equipment under the go sport brand; and invests in real estate properties, as well as manages a portfolio of private equity investments. as of december 31, 2019, it operated a portfolio of 11,172 stores. the company is based in paris, france. finatis société anonyme is a subsidiary of euris sas.

earnings per share

as for profitability, finatis has a trailing twelve months eps of €-32.99.

volume

today's last reported volume for finatis is 115 which is 14.81% below its average volume of 135.

volatility

finatis's last week, last month's, and last quarter's current intraday variation average was a negative 6.67%, a negative 5.71%, and a positive 7.68%.

finatis's highest amplitude of average volatility was 26.67% (last week), 14.98% (last month), and 7.68% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, finatis's stock is considered to be overbought (>=80).

more news about finatis (fnts.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com